In this study, a novel therapeutic strategy was devised to target TM4SF5-expressing cancer cells and suppress MACC-1 function using microRNA-encapsulated Ex, demonstrating promising anti-tumor effects both in vitro and in vivo. Here, TM4SF5 is linked to neoplasm.